Ninth Circuit Remands Royalty Dispute Over Zilactin

Law360, New York (September 5, 2007, 12:00 AM EDT) -- A federal appeals court has ruled that a lower court overstepped its bounds by determining that an agreement over royalties for a patent covering a herpes treatment was unenforceable.

The U.S. Court of Appeals for the Ninth Circuit on Wednesday found that the U.S. District Court for the District of Nevada wrongly applied a prior ruling by the Supreme Court to allow a patent holding company to stop making royalty payments to the inventor of the original patent of Zilactin, a liquid solution to treat herpes....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.